Bone News and Research

RSS

New discovery paves way for genetic screening test

Researchers at the Columbia University College of Dental Medicine have identified a genetic variation that raises the risk of developing serious necrotic jaw bone lesions in patients who take bisphosphonates, a common class of osteoclastic inhibitors.

27 Jan 2012

Rapid discontinuation of prednisone after kidney transplant can help prevent side effects

Rapid discontinuation of the immunosuppressive steroid prednisone after a kidney transplant can help prevent serious side effects, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology.

27 Jan 2012

New links between leukemia cells and osteoblasts

University of Rochester Medical Center researchers have discovered new links between leukemia cells and cells involved in bone formation, offering a fresh perspective on how the blood cancer progresses and raising the possibility that therapies for bone disorders could help in the treatment of leukemia.

27 Jan 2012

Amgen enters definitive merger agreement to acquire Micromet

Amgen and Micromet, Inc. today announced that the companies have entered into a definitive merger agreement under which Amgen will acquire Micromet, a biotechnology company founded in Germany with its research and development (R&D) center in Munich and headquarters in Rockville, Md., for $11 per share in cash.

27 Jan 2012

Libya: Detainees tortured and denied medical care

Detainees in the Libyan city of Misrata are being tortured and denied urgent medical care, leading the international medical humanitarian organisation Médecins Sans Frontières to suspend its operations in detention centres in Misrata, MSF announced today.

26 Jan 2012

Amorcyte commences enrollment in PreSERVE Phase 2 trial for acute myocardial infarction

Amorcyte, LLC, a NeoStem, Inc. company today announces the enrollment of the first patient in the Amorcyte PreSERVE Phase 2 trial for acute myocardial infarction.

25 Jan 2012

Enrollment complete in Medtronic's CoreValve U.S. Trial for severe aortic stenosis

Medtronic, Inc. today announced it has completed patient enrollment in the extreme risk study in its CoreValve U.S. Pivotal Trial. The company also received approval from the U.S. Food and Drug Administration (FDA) for an extended investigation to continue enrolling extreme risk patients under a Continued Access Study protocol.

From Medtronic 25 Jan 2012

Link between high fructose intake and cardiovascular risk in adolescents

Evidence of cardiovascular disease and diabetes risk is present in the blood of adolescents who consume a lot of fructose, a scenario that worsens in the face of excess belly fat, researchers report.

25 Jan 2012

Kids not getting enough Vitamin D

According to Dame Sally Davies, Chief Medical Officer (CMO) for England, young children and some adults are not getting enough vitamin D. Not receiving enough of the vitamin can lead to health problems including rickets, broken bones, muscle weakness and infections including TB. Research last year suggested that a quarter of Britain's toddlers did not have enough vitamin D in their bloodstreams.

24 Jan 2012

Heartburn drugs ineffective in kids with asthma: Study

A drug used to treat acid reflux has often been used for hard-to-treat asthma. A new study finds that it does not help children with the breathing disease and may cause side effects.

24 Jan 2012

Positive affect, self-affirmation help patients with chronic diseases to overcome obstacles

The experience of daily positive affect -- a mild, happy feeling -- and self-affirmation helps some patients with chronic diseases, including coronary artery disease, high blood pressure and asthma, make better decisions about their health.

24 Jan 2012

InSightec seeks FDA premarket approval for ExAblate treatment of pain palliation of bone metastases

InSightec Ltd, the leader in MR guided Focused Ultrasound therapy, announced that it has submitted a premarket approval application (PMA) to the U.S. Food and Drug Administration (FDA) for its ExAblate treatment of pain palliation of bone metastases.

24 Jan 2012

Patient enrollment complete in Enlivex Phase I/II clinical trial for autoimmune diseases

Hadasit Bio-Holdings a publicly traded portfolio of biotech companies, all based on intellectual property developed and owned by Hadassah University Hospital, Israel's foremost medical research center, today announced that the recruitment of 13 patients for the Enlivex Phase I/II clinical trial has been completed.

23 Jan 2012

NCI-funded project aims to shed new light on implications for bone metastasis in prostate cancer

Prostate cancer is the most frequent and second deadliest cancer men face. A team of Wayne State University researchers recently received $363,660 from the National Cancer Institute of the National Institutes of Health for the project - "Bone-induced c-kit in prostate cancer cells: implications for bone metastasis" - that aims to shed new light on implications for bone metastasis in prostate cancer.

21 Jan 2012

Research roundup: 'No individual mandate' scenarios; Breaking down health care expenditures

This paper expands 2011 research examining whether the health law's controversial individual mandate – which requires most people to have health insurance -- will be effective.

21 Jan 2012

Positive preliminary data from Exelixis' cabozantinib phase 2 trial on HCC

Exelixis, Inc. today reported positive preliminary data from the cohort of hepatocellular carcinoma (HCC) patients participating in the ongoing phase 2 randomized discontinuation trial (RDT) of cabozantinib.

20 Jan 2012

Technological breakthrough allows U-M Health System to reduce patients' radiation exposure

A technological breakthrough is allowing the University of Michigan Health System to be the first teaching hospital in the U.S. to perform some CT scans using a fraction of the radiation dose required for a conventional CT image.

20 Jan 2012

Wave of physical inactivity could have a major long-term health impact

Youngsters in Norway today are not as fit as earlier generations, and even the best perform less well. Researchers now warn that a wave of inactivity could have a major long-term health impact.

20 Jan 2012

Study finds older women can wait up to 15 years to repeat bone scans

Bone loss and osteoporosis develop so slowly in most women whose bones test normal at age 65 that many can safely wait as long as 15 years before having a second bone density test, researchers report in a new study. … Medicare pays for a bone density test every two years and many doctors have assumed that is the ideal interval, although national guidelines recommend them only at "regular intervals."

20 Jan 2012

MSC-mediated RNAi transfer holds promise for Huntington's disease

A team of researchers at the UC Davis Institute for Regenerative Cures has developed a technique for using stem cells to deliver therapy that specifically targets the genetic abnormality found in Huntington's disease, a hereditary brain disorder that causes progressive uncontrolled movements, dementia and death.

20 Jan 2012

Bone News and Research

New discovery paves way for genetic screening test

Rapid discontinuation of prednisone after kidney transplant can help prevent side effects

New links between leukemia cells and osteoblasts

Amgen enters definitive merger agreement to acquire Micromet

Libya: Detainees tortured and denied medical care

Amorcyte commences enrollment in PreSERVE Phase 2 trial for acute myocardial infarction

Enrollment complete in Medtronic's CoreValve U.S. Trial for severe aortic stenosis

Link between high fructose intake and cardiovascular risk in adolescents

Kids not getting enough Vitamin D

Heartburn drugs ineffective in kids with asthma: Study

Positive affect, self-affirmation help patients with chronic diseases to overcome obstacles

InSightec seeks FDA premarket approval for ExAblate treatment of pain palliation of bone metastases

Patient enrollment complete in Enlivex Phase I/II clinical trial for autoimmune diseases

NCI-funded project aims to shed new light on implications for bone metastasis in prostate cancer

Research roundup: 'No individual mandate' scenarios; Breaking down health care expenditures

Positive preliminary data from Exelixis' cabozantinib phase 2 trial on HCC

Technological breakthrough allows U-M Health System to reduce patients' radiation exposure

Wave of physical inactivity could have a major long-term health impact

Study finds older women can wait up to 15 years to repeat bone scans

MSC-mediated RNAi transfer holds promise for Huntington's disease

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News